Measles Vaccination: Weighing the Benefits and Risks of a Live Viral Vaccine for HIV-Infected Children

Measles Vaccination: Weighing the Benefits and Risks of a Live Viral Vaccine for HIV-Infected Children

Saved in:

Bibliographic Details
Format:	Article
Language:	English
Published:	Wiley 1996-01-01
Series:	Canadian Journal of Infectious Diseases
Online Access:	http://dx.doi.org/10.1155/1996/943202
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Measles-mumps-rubella vaccination experience in children with egg allergy
by: Öner Özdemir, et al.
Published: (2024-02-01)

A Cross-sectional Study to Understand the Reasons for Failure to Vaccinate Eligible Children with Measles-containing Vaccine among the Clinically Diagnosed Measles Cases during the Outbreak (2022) in a District of Maharashtra
by: Sudhir V Sane, et al.
Published: (2024-03-01)

Mumps Caused by an Inadequately Attenuated Measles, Mumps and Rubella Vaccine
by: WJ Bakker, et al.
Published: (2001-01-01)

Viral Live‐Attenuated Vaccines (LAVs): Past and Future Directions
by: Yan‐Dong Tang, et al.
Published: (2025-01-01)

Vaccination status of nursing and medical students against measles and associated factors
by: Pallysson Paulo da Silva, et al.
Published: (2025-01-01)

Management of Anticoagulants and Antiplatelet Agents in Elective Endoscopy: Weighing the Risks and Benefits
by: Paul J Belletrutti, et al.
Published: (2007-01-01)

Spatial analysis of measles cases and vaccination coverage in the Somali region, eastern Ethiopia
by: Abdilahi Ibrahim Muse, et al.
Published: (2025-02-01)

Regional Disparities in Measles Vaccination Coverage and Their Associated Factors: An Ecological Study in Japan
by: Masaki Machida, et al.
Published: (2025-02-01)

Impact of measles vaccination strategies on vaccination rates in low-income and middle-income countries: a systematic review and meta-analysis
by: Andrew Hayen, et al.
Published: (2025-02-01)

Benign Recurrent Sixth (Abducens) Nerve Palsy following Measles-Mumps-Rubella Vaccination
by: Areti Bourtoulamaiou, et al.
Published: (2015-01-01)

Measles seroprevalence in Thailand: are adolescents and young adults at risk of measles?
by: Panit Takkinsatian, et al.
Published: (2024-06-01)

Systematic collection, annotation, and pattern analysis of viral vaccines in the VIOLIN vaccine knowledgebase
by: Anthony Huffman, et al.
Published: (2025-02-01)

ULACNet-301, OPTIMO protocol: optimizing HPV vaccination regimen for cancer prevention in children and adolescents living with HIV
by: Delia Pinto-Santini, et al.
Published: (2025-01-01)

The Psychological Benefits of COVID-19 Vaccination
by: My Nguyen
Published: (2021-01-01)

Impact of Point-of-Care Testing on Diagnosis, Treatment, and Surveillance of Vaccine-Preventable Viral Infections
by: Kirthika Lakshmanan, et al.
Published: (2025-01-01)

Qualitative Insights on Barriers to Receiving a Second Dose of Measles-Containing Vaccine (MCV2), Oromia Region of Ethiopia
by: Kalkidan Solomon, et al.
Published: (2024-06-01)

Fractional-Order Epidemic Model for Measles Infection
by: Philip N. A. Akuka, et al.
Published: (2024-01-01)

Serum Mpox-specific IgG titers before and after breakthrough Mpox infection in an HIV-infected individual with viral suppression and prior 2-dose Mpox vaccination
by: Wang-Da Liu, et al.
Published: (2025-02-01)

Exploring Immune Responses through Dynamic Modeling of Cell-Immune Interactions in Viral Infection and Vaccination
by: Kwang Su Kim, et al.
Published: (2024-01-01)

Unilateral Optic Neuritis: A Rare Complication after Measles-Mumps-Rubella Vaccination in a 30-Year-Old Woman
by: Chiara De Giacinto, et al.
Published: (2016-01-01)

HIV viral load suppression rates among adults and children living with HIV in the North West Region of Cameroon: A call for action!
by: Gladys Fosah E Tayong, et al.
Published: (2025-01-01)

Obesity Is Not Associated with Impaired Immune Response to Influenza Vaccination in HIV-Infected Persons
by: Charitha Gowda, et al.
Published: (2015-01-01)

PROTACs: Mechanism and Bioavailability enhancement strategies by nanotechnology, RNA viral infections (vaccine strategy) and Prodrug development
by: Sanaul Mustafa, et al.
Published: (2025-01-01)

Clinical efficacy studies of the vaccine against feline panleukopenia, calicivirus infection and viral rhinotracheitis Carnifel PCH in kittens
by: T. S. Galkina, et al.
Published: (2024-06-01)

HIV Vaccine Research: The Challenge and the Way Forward
by: Hai-Bo Wang, et al.
Published: (2015-01-01)

Prevalence of non-vaccine high-risk HPV cervical infections in vaccinated women: a systematic review and meta-analysis
by: Glauciane Resende do Nascimento, et al.
Published: (2025-01-01)

Health belief model of parents’ COVID-19 vaccination intentions for children: perceived benefits and barriers in Indonesia
by: Eka Wuri Handayani, et al.
Published: (2025-01-01)

Measles Outbreaks in Afghanistan
by: Abubakr Yosufi, et al.
Published: (2024-03-01)

Modern vaccines and coronavirus infections
by: Yu. A. Belikova, et al.
Published: (2020-12-01)

Antibody-Dependent Cellular Cytotoxicity and NK Cell-Driven Immune Escape in HIV Infection: Implications for HIV Vaccine Development
by: Gamze Isitman, et al.
Published: (2012-01-01)

Mathematical Analysis of the Role of Treatment and Vaccination in the Management of the HIV/AIDS and Pneumococcal Pneumonia Co-Infection
by: Michael Byamukama, et al.
Published: (2025-01-01)

T Cell Costimulatory Molecules in Anti-Viral Immunity: Potential Role in Immunotherapeutic Vaccines
by: Tania H Watts, et al.
Published: (2003-01-01)

Sculpting multi-epitope vaccine against Monkeypox viral strains using immunoinformatics
by: Zaira Rehman, et al.
Published: (2025-01-01)

Results of experimental infection of vaccinated and non-vaccinated ducklings with duck hepatitis virus
by: A. A. Chesnokova, et al.
Published: (2022-12-01)

Live Plague Vaccine Development: Past, Present, and Future
by: Andrey P. Anisimov, et al.
Published: (2025-01-01)

Effectiveness and Cost-Benefit of an Influenza Vaccination Program for Health Care Workers
by: Annalee Yassi, et al.
Published: (1991-01-01)

Opportunities and Risks of Vaccination Progress
by: Veronika Grimm, et al.
Published: (2021-04-01)

OPTIMIZATION OF MEDICAL EVALUATION STRATEGIES IN VACCINATED WOMEN ANTI COVID-19, IN ROMANIA, TO IMPROVE THE LEVEL OF HESITATION AGAINST THE BENEFIT OF VACCINATION
by: Andreea Roxana Luca, et al.
Published: (2024-12-01)

Understanding human papillomavirus vaccine response and efficacy in people living with HIV: A systematic mixed studies review and meta-analysis.
by: Alvine M Akumbom, et al.
Published: (2024-01-01)

Risk Factors Regarding the Incomplete Vaccination Schedule in Children Under 5 Years
by: Andrés Sebastián Guevara Pabón, et al.
Published: (2024-09-01)